共 112 条
[1]
Zuberbier T(2021)The international EAACI/GA Allergy 77 734-766
[2]
Aberer W(2017)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria Eur Ann Allergy Clin Immunol 49 148-30
[3]
Asero R(2020)Justification for IgE as a therapeutic target in chronic spontaneous urticaria Alergologia Polska Polish J Allergol 7 29-5
[4]
Abdul Latiff AH(2022)Expert group commentary on the international recommendation for the management of urticaria: The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria Clin Exp Dermatol 47 2002-392
[5]
Baker D(2022)Cost-effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria Allergy 125 388-561
[6]
Ballmer-Weber B(2020)Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances Ann Allergy Asthma Immunol 91 557-1404
[7]
Sánchez-Borges M(2011)The impact of psychological stress on mast cells Acta Derm Venereol 9 1402-39
[8]
Sánchez-Borges M(2021)High Prevalence of Mental Disorders and Emotional Distress in Patients with Chronic Spontaneous Urticaria J Allergy Clin Immunol Pract 313 33-141
[9]
Caballero-Fonseca F(2020)Omalizumab improves perceived stress, anxiety, and depression in chronic spontaneous urticaria Arch Dermatol Res 68 131-13
[10]
González-Aveledo L(2012)The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study Allergy 29 2-263